Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;65(12):1285-90.
doi: 10.1590/s1807-59322010001200010.

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil

Collaborators, Affiliations

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil

Flair Jose Carrilho et al. Clinics (Sao Paulo). 2010.

Abstract

Objectives: We performed a national survey to update hepatocellular carcinoma (HCC) epidemiology in Brazil and determined the clinical and epidemiological profiles of patients with HCC in different Brazilian regions.

Methods: Data from 29 centers included 1,405 patients diagnosed with HCC from 2004 to 2009.

Results: The median age was 59 (1-92 years old; 78% male). At diagnosis, females were older than males (median age: 62 vs. 59 years old respectively; p<0.0001). Ninety-eight percent of the patients had cirrhosis (1279/1308). Hepatitis C virus was the main etiology (54%), followed by hepatitis B virus (16%) and alcohol (14%). In Southeastern and Southern Brazil, hepatitis C virus accounted for over 55% of cases. In the Northeast and North, hepatitis C virus accounted for less than 50%, and hepatitis B virus accounted for 22-25% of cases; hepatitis B was more prevalent in the Northern than in the Southern regions. Some 43%, 35%, and 22% of patients were in early, intermediate, and advanced stages respectively. Initial therapies for HCC included chemoembolization or embolization (36%), percutaneous ablation (13%), liver resection (7%), and sorafenib (1%). Liver transplantation was performed in 242 patients (19%), but it was the initial therapy for only 56 patients (4%).

Conclusion: The epidemiology, classification, and therapy selection for HCC varied among Brazilian regions. Hepatitis C infection was the most common etiology of liver cirrhosis; chemoembolization was the most common therapy employed. Liver cirrhosis was the main risk factor for HCC development in Brazil.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of patients according to HCC etiology and Brazilian region.
Figure 2
Figure 2
Distribution of patients according to HCC classification and Brazilian region.
Figure 3
Figure 3
Distribution of patients according to initial HCC therapy and Brazilian region.
Figure 4
Figure 4
Distribution of patients according to initial HCC therapy and classification.

Similar articles

Cited by

References

    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. 10.3322/canjclin.55.2.74 - DOI - PubMed
    1. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35–50. 10.1053/j.gastro.2004.09.014 - DOI - PubMed
    1. Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191–211. 10.1016/j.cld.2004.12.009 - DOI - PubMed
    1. El‐Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27–34. 10.1053/j.gastro.2004.09.013 - DOI - PubMed
    1. Gonçalves CS, Pereira FE, Gayotto LC. Hepatocellular carcinoma in Brazil: report of a national survey (Florianópolis, SC, 1995) Rev Inst Med Trop Sao Paulo. 1997;39:165–70. - PubMed

MeSH terms